Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.400
+0.020 (1.45%)
At close: Nov 20, 2024, 4:00 PM
1.440
+0.040 (2.86%)
Pre-market: Nov 21, 2024, 7:29 AM EST
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$63,759
Profits / Employee
-$208,344
Market Cap
5.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Cutera | 430 |
Biora Therapeutics | 58 |
Ainos | 46 |
Aptevo Therapeutics | 40 |
Viracta Therapeutics | 40 |
TransCode Therapeutics | 10 |
Alzamend Neuro | 7 |
Xenetic Biosciences | 4 |
INBS News
- 21 days ago - Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - GlobeNewsWire
- 23 days ago - Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles - Newsfile Corp
- 5 weeks ago - Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution - GlobeNewsWire
- 7 weeks ago - GPS Marine Adopts Intelligent Bio Solutions' Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission - GlobeNewsWire
- 2 months ago - UK's Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions' Fingerprint Drug Test to Enhance Workplace Safety - GlobeNewsWire